Agilent Technologies has inked a deal to acquire Seahorse Bioscience, adding a cell metabolism analysis platform to its lead development and preclinical offerings.
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
A mathematical algorithm that predicts the effects a compound will
have on a cell's molecular components, will prove significant to
drug developers, who can design compounds that will act on desired
targets, eliciting therapeutic...
Cambrex has made a second deal to increase its presence in the
microbiological testing, this time acquiring France's Genolife for
approximately $6 million (€4.75m) in cash.
Amersham will no longer act as a distributor for Epoch Bioscience's
MGB Eclipse range of probe systems after failing to meet sales
targets, according to the latter company.